Tarbox Family Office, Inc. Lexicon Pharmaceuticals, Inc. Transaction History
Tarbox Family Office, Inc.
- $606 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding LXRX
# of Institutions
137Shares Held
244MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$69.5 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$19.8 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$5.04 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$5.04 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$4.58 Million0.02% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $96.3M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...